Pancreatic sarcomatoid carcinoma: CT, MRI, and 18F-FDG PET/CT features

Zhao, Shuai; Su, Weiwei; Deng, Lulu; Chen, Y.; Zuo, Chuantao; Shao, Chengwei; Ren, Fangyuan

doi:10.1016/j.crad.2020.01.003

Cited by 5 publications

(3 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, EUS still cannot be popularized in domestic hospitals while only installed in some large medical institutions. Although positron emission tomography/computed tomography (PET/CT) has been widely used in the diagnosis of tumors, its conventional tracer 18F-fluorodeoxyglucose (18F-FDG) has little effect in the detection of early pancreatic ductal adenocarcinoma ( 36 , 37 ).…”

Section: Current Status Of Diagnosis Of Pancreatic Cancermentioning

confidence: 99%

Multidisciplinary team diagnosis and treatment of pancreatic cancer: Current landscape and future prospects

Yao

Chen²,

Fan³

et al. 2023

Front. Oncol.

View full text Add to dashboard Cite

The pathogenesis of pancreatic cancer has not been completely clear, there is no highly sensitive and specific detection method, so early diagnosis is very difficult. Despite the rapid development of tumor diagnosis and treatment, it is difficult to break through in the short term and the overall 5-year survival rate of pancreatic cancer is less than 8%. In the face of the increasing incidence of pancreatic cancer, in addition to strengthening basic research, exploring its etiology and pathogenesis, it is urgent to optimize the existing diagnosis and treatment methods through standard multidisciplinary team (MDT), and formulate personalized treatment plan to achieve the purpose of improving the curative effect. However, there are some problems in MDT, such as insufficient understanding and enthusiasm of some doctors, failure to operate MDT according to the system, lack of good communication between domestic and foreign peers, and lack of attention in personnel training and talent echelon construction. It is expected to protect the rights and interests of doctors in the future and ensure the continuous operation of MDT. To strengthen the research on the diagnosis and treatment of pancreatic cancer, MDT can try the Internet +MDT mode to improve the efficiency of MDT.

show abstract

Section: Current Status Of Diagnosis Of Pancreatic Cancermentioning

confidence: 99%

Multidisciplinary team diagnosis and treatment of pancreatic cancer: Current landscape and future prospects

Yao

Chen²,

Fan³

et al. 2023

Front. Oncol.

View full text Add to dashboard Cite

show abstract

“…Primary sarcomatoid carcinoma of the esophagus is rare, accounting for approximately 2% of esophageal carcinomas. [1][2][3][4][5][6] The most common clinical presentation of esophageal sarcomatoid carcinoma is dysphagia, chest pain, or fever. [6][7][8][9] However, none of these clinical symptoms are specific, so as imaging findings.…”

mentioning

confidence: 99%

“…Sarcomatoid carcinoma is a highly malignant neoplasm that usually arises in the lung, sometimes in the uterus, gallbladder, adrenal, or pancreas. Primary sarcomatoid carcinoma of the esophagus is rare, accounting for approximately 2% of esophageal carcinomas 1–6 . The most common clinical presentation of esophageal sarcomatoid carcinoma is dysphagia, chest pain, or fever 6–9 .…”

mentioning

confidence: 99%

A Case of Primary Esophageal Sarcomatoid Carcinoma Detected by 18F-FDG PET/CT

Chen,

Li,

Fan

2023

Clin Nucl Med

View full text Add to dashboard Cite

Primary sarcomatoid carcinoma of the esophagus is a rare and highly malignant neoplasm with a poor prognosis. A 51-year-old man presented with difficulty in swallowing for 2 weeks. Thoracic CT revealed a huge mass in the middle-lower thoracic esophagus. 18F-FDG PET/CT showed intense 18F-FDG uptake of the esophageal tumor. Histopathology and immunohistochemistry of the esophageal lesion tissue confirmed the diagnosis of sarcomatoid carcinoma after postoperative pathological biopsy.

show abstract